Novel lanthanum vanadate-based nanocomposite for simultaneously electrochemical detection of dopamine and uric acid in fetal bovine serum

The abnormal levels of two biological molecules, dopamine (DA) and Uric acid (UA), in human body are symptoms of diseases such as Parkinson's disease and arrhythmia. A novel lanthanum vanadate and multi-walled carbon nanotubes (LaV-MWCNTs) composite modified glassy carbon electrode (GCE) was developed and utilized as an efficient electrochemical sensor for the simultaneous detection of DA and UA. LaV-MWCNTs composite was successfully fabricated by a facile ultrasonic self-assembly method and identified by means of a series of successive measurements including XPS, XRD, FT-IR and FE-SEM. The LaV-MWCNTs modified GCE shows the concentration linear ranges of DA and UA are 2–100 μΜ using DPV. The limits of detection (LODs; signal-to-noise ratio of 3, S/N = 3) of the LaV-MWCNTs modified GCE sensor for DA and UA were calculated to be 0.046 μM and 0.025 μM, respectively. The feasibility of using the LaV-MWCNTs modified GCE sensor to detect DA and UA in a typical biological fluid, fetal bovine serum, was also evaluated by the standard addition method.